Moderna’s vaccine is one of 11 experimental vaccines in final stage trials.
Trump, whose approval has taken a hit over his handling of the Covid-19 crisis, has frequently hinted a vaccine could be ready before the November 3 vote.
- AFP Washington
- Last Updated: October 1, 2020, 1:56 AM IST
- FOLLOW US ON:
US biotech firm Moderna won’t seek an emergency use authorisation for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.
The news deals a blow to President Donald Trump’s hopes of having an injection ready before the election to give his campaign a much-needed boost.
Stephane Bancel told the newspaper: “November 25 is the time we will have enough safety data to be able to put into an EUA file that we would send to the FDA (Food and Drug Administration) — assuming that the safety data is good, i.e. a vaccine is deemed to be safe.”
Trump, whose approval…